Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million. Market Access The value of a partner, globally and locally.

Cancer Research UK and its commercialisation arm are to work with UK biotech firm Bicycle Therapeutics on a novel approach to targeting cancer.